Brief: China Regenerative Medicine International says unit to sell Shaanxi Aimiya to third party

China Regenerative Medicine International

18/10/2017 14:59

Oct 18 (Reuters) - China Regenerative Medicine International 
Ltd  8158.HK : 
    * Unit entered into deal to sell 100 percent stake in 
Shaanxi Aimiya to third party buyer 
    * Estimated gain on disposal of about RMB28.6 million to be 
recorded in group's FY ending Dec. 31, 2017 
    * Unit to also sell loan to third party purchaser;  
consideration for SPA and loan RMB40 million 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nHKS42q6xl 
Further company coverage:  8158.HK  
 
 (bangalore.newsroom@thomsonreuters.com)